Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

174.80
Delayed Data
As of Aug 04
 -0.79 / -0.45%
Today’s Change
124.81
Today|||52-Week Range
181.81
+9.74%
Year-to-Date

Today’s Trading

Previous close175.59
Today’s open175.79
Day’s range173.62 - 176.22
Volume2,474,168
Average volume (3 months)3,272,671
Market cap$133.5B
Dividend yield1.81%
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+11.79%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.30%
P/E ratio23.6
Price/Sales6.12
Price/Book5.18

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.73-0.61%
BIIBBiogen+6.00+1.85%
BXLTBaxalta Inc+3.95+11.92%
BAXBaxter International...+0.80+2.02%
Data as of 08/04/2015

Financials

Next reporting dateOctober 20, 2015
EPS forecast (this quarter)$2.36
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts